Clinical Trial Update: Neoadjuvent Dose-dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 neoadjuvant trial of dose-dense gemcitabine and cisplatin in muscle-invasive bladder cancer; the study status is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Assiut University | Conditions: Urinary Bladder Cancer | Phase 2 | Status: NOT_YET_RECRUITING